Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Understand Emotions, Become Profitable | Main | Laptop Crashed »

November 24, 2003

The Neurotech Business Carnival

Email This Entry

Posted by Zack Lynch

Neurotech Business Reports overviews the most recent business news from across the neurotechnology industry. Among the highlights:

- Analysts probe into issues related to commercializing neuroprostheses
- Market projections suggest growth from $2.4B 2004 to $7.2B in 2008
- James Cavuoto reacts to monkey's controlling a robot arm with cortical implants
- Research Institution Profile: UCSF at forefront of neurostimulation devices
- Vendor Profile: Neurome parlays brain database into neuropharma contracts
- For the whole report

Also, don't forget to check out this week's "Carnival of the Capitalists".

Comments (0) | Category: Neurotech Industry



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives